| Literature DB >> 24900483 |
John H Cardellina1, Virginia I Roxas-Duncan1, Vicki Montgomery1, Vanessa Eccard1, Yvette Campbell1, Xin Hu2, Ilja Khavrutskii2, Gregory J Tawa2, Anders Wallqvist2, James B Gloer3, Nisarga L Phatak3, Ulrich Höller3, Ashish G Soman3, Biren K Joshi3, Sara M Hein3, Donald T Wicklow4, Leonard A Smith5.
Abstract
An in silico screen of the NIH Molecular Library Small Molecule Repository (MLSMR) of ∼350000 compounds and confirmatory bioassays led to identification of chaetochromin A (1) as an inhibitor of botulinum neurotoxin serotype A (BoNT A). Subsequent acquisition and testing of analogues of 1 uncovered two compounds, talaroderxines A (2) and B (3), with improved activity. These are the first fungal metabolites reported to exhibit BoNT/A inhibitory activity.Entities:
Keywords: binding free energy; botulinum neurotoxin serotype A; chaetochromin; in silico screen; natural products; talaroderxine; thermodynamic integration
Year: 2012 PMID: 24900483 PMCID: PMC4025784 DOI: 10.1021/ml200312s
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345